[1]邱敏 林秀石 田晓军 陆敏① 卢剑 侯小飞 赵磊 王国良 马潞林 张树栋**.透明细胞乳头状肾细胞肿瘤23例的临床特点及术后中长期随访报告[J].中国微创外科杂志,2024,01(11):721-725.
　Qiu Min,Lin Xiushi,Tian Xiaojun,et al.Clinical Characteristics and Medium to Longterm Followups of Surgery for 23 Cases of Clear Cell Papillary Renal Cell Tumor[J].Chinese Journal of Minimally Invasive Surgery,2024,01(11):721-725.
点击复制

透明细胞乳头状肾细胞肿瘤23例的临床特点及术后中长期随访报告()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2024年11期
页码:
721-725
栏目:
临床论著
出版日期:
2024-11-25

文章信息/Info

Title:
Clinical Characteristics and Medium to Longterm Followups of Surgery for 23 Cases of Clear Cell Papillary Renal Cell Tumor
作者:
邱敏 林秀石 田晓军 陆敏① 卢剑 侯小飞 赵磊 王国良 马潞林 张树栋**
(北京大学第三医院泌尿外科，北京100191)
Author(s):
Qiu Min;  Lin Xiushi;  Tian Xiaojun;  et al.
Department of Urology, Peking University Third Hospital, Beijing 100191, China
关键词:
透明细胞乳头状肾细胞肿瘤; 腹腔镜手术; 机器人手术
Keywords:
Clear cell papillary renal cell tumor; Laparoscopic surgery; Robotassisted laparoscopic surgery
文献标志码:
A
摘要:
目的探讨透明细胞乳头状肾细胞肿瘤的临床病理特点及手术后中长期效果。方法2013年10月~2024年1月，我科对23例透明细胞乳头状肾细胞肿瘤分别行肾部分切除术或根治性肾切除术。行肾部分切除术者，通过经腹入路或经腹膜后入路，游离并阻断肾动脉，切除肿瘤并对创面进行缝合。行根治性肾切除术者，游离肾动静脉及输尿管，Hemolok夹闭后切断，再将肾脏装袋取出。结果手术均顺利完成，18例腹腔镜手术，5例机器人辅助腹腔镜手术。17例行肾部分切除术，手术时间73~229 min，中位数149 min；阻断时间9~35 min，中位数21 min；出血量10~100 ml，中位数20 ml；术后住院时间3~28 d，中位数6 d。6例行根治性肾切除术，手术时间110~232 min，中位数123 min；出血量5~200 ml，中位数10 ml；术后住院时间3~7 d，平均4 d。术后病理均为透明细胞乳头状肾细胞肿瘤，核分级(WHO/ISUP分级)Ⅰ~Ⅱ级。23例术后随访7~121个月，平均53个月,其中10例随访>3年，9例随访>5年。1例术后1年发现对侧肾脏病变行腹腔镜肾部分切除术，病理为透明细胞乳头状肾细胞肿瘤，此后复查显示双肾有囊肿，距第1次术后7年发现双肾实性结节，考虑复发，主动监测2年(每3~6个月复查CT)，病情稳定；1例术后29个月发现贲门管状腺癌，行胃镜下切除，随访121个月无复发；余21例无复发。结论透明细胞乳头状肾细胞肿瘤术前诊断困难，手术是有效治疗方法，预后较好，但部分病例会复发或合并多原发癌，术后应注意复查。
Abstract:
ObjectiveTo investigate the clinicopathologic characteristics of clear cell papillary renal cell tumor and the medium to longterm effect of surgical treatment.MethodsA total of 23 cases of clear cell papillary renal cell tumor treated in our department from October 2013 to January 2024 were retrospectively analyzed. For patients undergoing partial nephrectomy, the renal artery was dissociated and blocked through abdominal or retroperitoneal approach to remove the tumor, and then the wound was sutured. For patients undergoing radical nephrectomy, the renal artery, vein, and ureter were dissociated and clipped by Hemolok for cutting off, and then the kidney was removed.ResultsThe operations were accomplished in all the patients, including 18 laparoscopic operations and 5 robotassisted laparoscopic operations. Among them, 17 cases underwent partial nephrectomy, with an operating time of 73-229 min (median, 149 min), blocking time of 9-35 min (median, 21 min), blood loss of 10-100 ml (median, 20 ml), and postoperative hospitalization time of 3-28 d (median, 6 d). Six cases underwent radical nephrectomy, with an operating time of 110-232 min (median, 123 min), blood loss of 5-200 ml (median, 10 ml), and postoperative hospitalization time of 3-7 d (median, 4 d). Postoperative pathology showed clear cell papillary renal cell tumor with nuclear grade (WHO/ISUP grade) of Ⅰ-Ⅱ. The 23 cases were followed up for 7-121 months (mean, 53 months), of which 10 cases were followed up for more than 3 years and 9 cases for more than 5 years. One case was found to have contralateral renal lesions one year after operation and underwent laparoscopic partial nephrectomy, with a pathological result of clear cell papillary renal cell tumor. Subsequent reexaminations showed that there were cysts in both kidneys. At 7 years after the first operation, solid nodules in both kidneys were found, and a recurrence was considered. The patient was given active monitoring for 2 years (CT reexaminations every 3-6 months) and was in stable condition. Another case was found gastric cardia tubular adenocarcinoma at 29 months after operation and was resected under gastroscopy. No recurrence was found during followups for 121 months. The remaining 21 cases had no recurrence.ConclusionsPreoperative diagnosis of clear cell papillary renal cell tumor is difficult, and surgery is an effective method for treating this disease. Medium to longterm followup shows a good prognosis, but there are still some cases of recurrence or combined with multiple primary cancer. Postoperative followups should be noted.

参考文献/References:

[1]邱敏,卢剑,马潞林,等.透明细胞乳头状肾细胞癌的诊治经验.中华泌尿外科杂志,2016,37(9):655-659.
[2]Tickoo SK, DeperaltaVenturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in endstage renal disease: an experience from 66 tumorbearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol,2006,30(2):141-153.
[3]王亦秋,顾民.透明细胞乳头状肾细胞癌的研究进展.南京医科大学学报(自然科学版),2018,38(1):130-137.
[4]Steward JE, Kern SQ, Cheng L, et al. Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional series.Urol Oncol,2021,39(6):370.e21-370.e25.
[5]Rysz J, Franczyk B, awiński J, et al. Characteristics of clear cell papillary renal cell carcinoma (ccpRCC). Int J Mol Sci,2021,23(1):151.
[6]陆泽华,冒炜,殷慧康,等.透明细胞乳头状肾细胞癌的影像学表现.医学影像学杂志,2021,31(4):624-628.
[7]Wang K, Zarzour J, RaisBahrami S, et al. Clear cell papillary renal cell carcinoma: new clinical and imaging characteristics. Urology,2017,103:136-141.
[8]Anderson DA, Tretiakova MS. Primary renal carcinoid with bilateral multiple clear cell papillary renal cell carcinomas. Case Rep Pathol,2017,2017:9672368.
[9]David H, Alexei M, Jeffrey R, et al. Clear cell papillary renal cell carcinoma in a transplant kidney Can J Urol,2019,26(3):9794-9798.
[10]Bing Z, Tomaszewski JE. Clear cell papillary renal cell carcinoma in the bilateral native kidneys after 2?years of renal transplantation: Report of a case and review of the literature. Case Rep Transplant, 2011,2011:387645.
[11]Tian X, Xu W, Wu J, et al. Clear cell papillary renal cell carcinoma shares distinct molecular characteristics and may be significantly associated with higher risk of developing second primary malignancy. Pathol Oncol Res,2021,27:1609809.
[12]Song Y, Yang R, Zhang X, et al. Diagnostic value of imaging in patients with clear cell papillary renal cell carcinoma: A case series and literature review. J Clin Ultrasound,2024 May 13. Online ahead of print.
[13]Banno T, Takagi T, Kondo T, et al. Computed tomography imaging characteristics of clear cell papillary renal cell carcinoma. Int Braz J Urol,2020,46(1):26-33.
[14]简远熙，陈梦林,柳瑞,等.透明细胞乳头状肾细胞肿瘤的CT和MRI表现.中国医学影像学杂志,2023,31(4):405-409.
[15]Lin X. Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology. Cytopathology,2024,35(4):481-487.
[16]Williamson SR. Clear cell papillary renal cell carcinoma: an update after 15 years. Pathology,2021,53(1):109-119.
[17]Griffin BB, Lin X. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features. Cancer Cytopathol,2021,129(3):192-203.
[18]Martignoni G, Brunelli M, Segala D, et al. Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker. Pathology,2017,49(1):10-18.
[19]王昕凝,祖强,黄双,等.后腹腔镜、机器人腹腔镜、机器人后腹腔镜肾部分切除术的比较:单一术者经验.中国微创外科杂志,2018,18(10):874-877，898.
[20]张洪宪,秦艳春,赵勋,等.不停用抗血小板药物行后腹腔镜肾部分切除术5例.中国微创外科杂志,2021,21(5):459-463.
[21]徐亚威,周靖程,谢海标,等.透明细胞乳头状肾细胞癌的临床病理及预后特点.中华医学杂志,2021,101(46):3784-3788.
[22]Weng S, DiNatale RG, Silagy A, et al. The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: implications in diagnosis and management. Eur Urol,2021,79(4):468-477.
[23]Wang Y, Ding Y, Wang J, et al. Clinical features and survival analysis of clear cell papillary renal cell carcinoma: A 10year retrospective study from two institutions. Oncol Lett,2018,16(1):1010-1022.
[24]Mohanty SK, Lobo A, Cheng L. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges.Hum Pathol,2023,136:123-143.
[25]顾宇峰,达建萍,周昱霖,等.透明细胞乳头状肾细胞癌临床病理特征与预后分析.现代泌尿外科杂志,2023,28(3):186-191.
[26]邢自宝,周毅,李金雨.基于SEER数据库的肾透明细胞乳头状肾细胞癌患者临床特征及生存分析.现代泌尿外科杂志,2023,28(2):137-140.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（面上项目）（82273389）**通讯作者，Email：zhangshudong@bjmu.edu.cn ①病理科
更新日期/Last Update: 2025-02-10